Hamburg based company, Indivumed announced the expansion of its clinical network in Asia, Europe and South America including six additional, large clinical systems.
With the first sites in Japan and Korea, Indivumed strengthens its Asian footprint, adding to previous activities in Singapore and India.
With these hospitals, more than 30 clinical systems from 10 countries and four continents are applying Indivumed’s standardized, proprietary processes that preserve the integrity of the tissue biology.
The additional locations
- Asia: Japan, Chiba (National Cancer Center Hospital East) and South Korea, Seoul (Yonsei University Healthcare System-Severance Hospital)
- South America: Brazil, Salvador (AMO Clinics)
- Europe: Spain, Lleida (Hospital Universitari Arnau de Vilanova), Spain, Madrid (Hospital Universitario Fundación Jiménez Díaz) and Spain, Santiago (Complejo Hospitalario Universitario de Santiago).
Ongoing discussions include additional hospitals in Europe, US, Central and South America.
Indivumed is a physicians-led, integrated global oncology company.
